Earnings History Data for Onconova Therapeutics, Inc. (ONTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company's products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV, ON 013105 and Recilisib. Onconova Therapeutics, Inc. is headquartered in Newtown, Pennsylvania.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2023	AH		ONTX	Onconova Therapeutics, Inc.	13.43	-0.23	-0.26	-0.26	Onconova Therapeutics GAAP EPS of -$0.23 beats by $0.06, revenue of $0.06M misses by $0.01M [11/14/2023 4:07 PM]	0.6449	-0.02 (-2.29%)	0.66	0.0 (0.39%)	0.55 - 1.49	56,084	40,000	2,540
Onconova Therapeutics GAAP EPS of -$0.23 beats by $0.06, revenue of $0.06M misses by $0.01M [11/14/2023 4:07 PM]
10-08-2023	AH		ONTX	Onconova Therapeutics, Inc.	20.55	-0.20	-0.29	-0.19	Onconova Therapeutics GAAP EPS of -$0.20 beats by $0.11, revenue of $0.06M misses by $0.01M [8/10/2023 4:26 PM]	0.9624	-0.06 (-5.65%)	1.00	-0.02 (-1.96%)	0.62 - 1.49	52,634	50,000	824
Onconova Therapeutics GAAP EPS of -$0.20 beats by $0.11, revenue of $0.06M misses by $0.01M [8/10/2023 4:26 PM]
15-05-2023	AH	4:05 PM ET (May 15)	ONTX	Onconova Therapeutics, Inc.	24.95	-0.28	-0.27	-0.20	Onconova Therapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $0.06M misses by $0.02M [5/15/2023 4:21 PM]	1.15	-0.03 (-2.54%)	1.16	-0.02 (-1.69%)	0.62 - 1.52	116,330	280,000	1,924
Onconova Therapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $0.06M misses by $0.02M [5/15/2023 4:21 PM]
16-03-2023	AH	4:05 PM ET (Mar 16)	ONTX	Onconova Therapeutics, Inc.	18.62	-0.26	-0.27	-0.16	Onconova Therapeutics GAAP EPS of -$0.91 misses by $0.63, revenue of $0.23M beats by $0.17M [3/16/2023 4:08 PM]	0.78	0.0 (-0.64%)	0.83	0.04 (5.72%)	0.62 - 2.04	102,974	60,000	1,298
Onconova Therapeutics GAAP EPS of -$0.91 misses by $0.63, revenue of $0.23M beats by $0.17M [3/16/2023 4:08 PM]
14-11-2022	AH	4:05 PM ET (Nov 14)	ONTX	Onconova Therapeutics	14.00	-0.26	-0.21	0.00	Onconova Therapeutics GAAP EPS of -$0.26 misses by $0.05, revenue of $0.06M misses by $0.01M [11/14/2022 4:09 PM]	0.84	-0.04 (-4.55%)	0.84	-0.04 (-4.55%)	0.65 - 3.60	299,634	110,000	16,958
Onconova Therapeutics GAAP EPS of -$0.26 misses by $0.05, revenue of $0.06M misses by $0.01M [11/14/2022 4:09 PM] Onconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates [Nov-14-22 05:25PM] Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update [Nov-14-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	ONTX	Onconova Therapeutics, Inc.	25.70	-0.19	-0.20	-0.27	Onconova Therapeutics GAAP EPS of -$0.19 beats by $0.01, revenue of $0.06M in-line [8/11/2022 4:08 PM]	1.33	0.02 (1.32%)	1.30	-0.02 (-1.34%)	1.00 - 6.77	96,365	240,000	2,751
Onconova Therapeutics GAAP EPS of -$0.19 beats by $0.01, revenue of $0.06M in-line [8/11/2022 4:08 PM]
11-05-2022	AH	4:05 PM ET (May 11)	ONTX	Onconova Therapeutics, Inc.	24.45	-0.20	-0.18	-0.30	Onconova Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $0.06M misses by $0.02M [5/11/2022 4:08 PM]	1.02	-0.06 (-5.56%)	1.00	-0.09 (-7.87%)	1.00 - 16.50	215,511	110,000	6,155
Onconova Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $0.06M misses by $0.02M [5/11/2022 4:08 PM] Onconova Q1 net loss narrows 13% although revenue remains flat [5/11/2022 5:40 PM] Collegium Pharmaceutical (COLL) Lags Q1 Earnings Estimates [May-10-22 05:55PM] Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y [May-11-22 11:20AM] Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update [May-11-22 04:05PM] Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug [May-12-22 10:20AM]
17-03-2022	AH	4:00 PM ET (Mar 17)	ONTX	Onconova Therapeutics, Inc.	31.34	-0.16	0.00	-0.45	Onconova Therapeutics GAAP EPS of -$0.96 misses by $0.04, revenue of $0.23M in-line [3/17/2022 4:07 PM]	1.76	-0.10 (-5.38%)	1.74	-0.12 (-6.45%)	1.38 - 19.20	174,559	231,085	7,123
Onconova Therapeutics GAAP EPS of -$0.96 misses by $0.04, revenue of $0.23M in-line [3/17/2022 4:07 PM] Onconova Therapeutics shares fall after wider-than-expected FY loss [3/18/2022 1:06 PM] Onconova Therapeutics Reports Full Year 2021 Financial Results and Provides Business Update [Mar-17-22 04:05PM]
11-11-2021	AH	4:05 PM ET (Nov 11)	ONTX	Onconova Therapeutics, Inc.	55.23	-0.22	-0.32	-0.45	Onconova Therapeutics EPS beats by $0.11, beats on revenue [11/11/2021 4:02 PM]	3.45	-0.04 (-1.15%)	3.49	0.0 (0.00%)	3.35 - 28.95	336,331	390,000	1,642
Onconova Therapeutics EPS beats by $0.11, beats on revenue [11/11/2021 4:02 PM] Onconova Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-11-21 04:01PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	ONTX	Onconova Therapeutics, Inc.	80.01	-0.27	-0.28	-0.60	Onconova Therapeutics EPS beats by $0.01, beats on revenue [8/12/2021 4:07 PM]	4.95	-0.23 (-4.44%)	5.11	-0.07 (-1.35%)	2.85 - 28.95	357,148	210,000	2,443
Onconova Therapeutics EPS beats by $0.01, beats on revenue [8/12/2021 4:07 PM] Onconova Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-12-21 04:05PM] Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Tops Revenue Estimates [Aug-12-21 07:25PM]
17-05-2021	AH	4:05 PM ET (May 17)	ONTX	Onconova Therapeutics, Inc.	119.00	-0.02	-0.03	0.00	Onconova Therapeutics EPS beats by $0.01, revenue in-line [5/17/2021 4:09 PM]	1.08	0.46 (75.04%)	0.79	0.17 (28.20%)	0.19 - 1.93	219,611,310	7,800,000	10,104,473
Onconova shares fall after Q1 results, cash position update [5/17/2021 4:23 PM] Onconova Therapeutics EPS beats by $0.01, revenue in-line [5/17/2021 4:09 PM] Onconova climbs after Guggenheim initiated coverage with a Street high target [5/18/2021 8:44 AM] Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update [May-17-21 04:05PM] Onconova Therapeutics, Inc. to Host Earnings Call [May-17-21 02:45PM] 7 Reddit Penny Stocks Promising to Cure Cancer [May-14-21 10:25AM]
11-03-2021	AH	4:05 PM ET (Mar 11)	ONTX	Onconova Therapeutics, Inc.	235.33	-0.03	-0.04	0.00	Onconova Therapeutics EPS in-line, beats on revenue [3/11/2021 4:19 PM]	1.10	-0.02 (-2.21%)	1.07	-0.06 (-5.31%)	0.19 - 1.93	14,797,050	33,673,920	780,456
Onconova Therapeutics EPS in-line, beats on revenue [3/11/2021 4:19 PM] Onconova Therapeutics, Inc. to Host Earnings Call [Mar-11-21 02:30PM] Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update [Mar-11-21 04:05PM]
12-11-2020	AH	4:05 PM ET (Nov 12)	ONTX	Onconova Therapeutics, Inc.	50.21	-0.03	-0.02	-0.75	Onconova Therapeutics EPS in-line, misses on revenue [11/12/2020 4:12 PM]	0.2636	-0.03 (-9.66%)	0.2650	-0.03 (-9.18%)	0.10 - 1.56	8,380,165	5,033,189	365,122

12-08-2020	AH	4:05 PM ET (Aug 12)	ONTX	Onconova Therapeutics, Inc.	195.08	-0.04	-0.03	-0.60	Onconova Therapeutics EPS misses by $0.01, misses on revenue [8/12/2020 4:11 PM]	1.02	-0.04 (-4.22%)	1.05	-0.01 (-0.96%)	0.10 - 2.84	4,357,707	8,945,682	356,877

14-05-2020	AH	6:55 PM ET (May 14)	ONTX	Onconova Therapeutics, Inc.	65.76	-0.03	-0.04	-1.29	Onconova Therapeutics EPS beats by $0.03, misses on revenue [5/14/2020 4:12 PM]	0.3609	0.0 (0.25%)	0.35	-0.01 (-3.02%)	0.10 - 4.16	16,337,482	7,384,824	662,823